Summary
The metabolism of 7-(4-chlorbenzyl)-7,8,13,13a-tetrahydroberberine chloride (CTHB), a compound with promising pharmacological effects against arrhythmia, was investigated in rat bile. A metabolite and unchanged CTHB were found in the bile. Characterization and structural elucidation of the metabolite was achieved by LC/MS and LC/NMR. The following metabolic pathway is proposed: CTHB is metabolized by demethylation at position 10 to produce a new entity.
Similar content being viewed by others
Reference
Sklenar V., Piotto M., Leppik R., Saudek V. (1993): Gradienttailored water suppression for H-N SHQC experiments optimized to retain full seneitity. J. Magn. Reson. (Series A), 102, 241–245.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Feng, N., Zhang, Z., An, D. et al. Investigation of the metabolism of 7-(4-chlorbenzyl)-7,8,13,13a-tetrahydroberberine chloride in the rat. European Journal of Drug Metabolism and Pharmacokinetics 23, 41–44 (1998). https://doi.org/10.1007/BF03189825
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189825